HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. Founded in 2011, HOOKIPA has made significant strides in the field, particularly with its proprietary platform that harnesses the power of viral vectors to stimulate robust immune responses. The company operates primarily in the oncology and infectious disease sectors, offering unique therapies that stand out for their ability to target specific antigens effectively. HOOKIPA's lead product candidates, including its promising therapies in clinical trials, exemplify its commitment to advancing treatment options. With a strong market position and notable achievements in research and development, HOOKIPA Pharma continues to be at the forefront of biopharmaceutical innovation, striving to improve patient outcomes globally.
DitchCarbon Score
How does HOOKIPA Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HOOKIPA Pharma Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HOOKIPA Pharma Inc.'s reported carbon emissions
HOOKIPA Pharma Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or initiatives related to climate commitments. Without emissions data or defined climate strategies, it is unclear how HOOKIPA Pharma Inc. is addressing its environmental impact. The absence of reported figures suggests a need for further transparency in their climate-related efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HOOKIPA Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
